Relation Between Macrophage Inflammatory Protein-1 and Intercellular Adhesion Molecule-1 and Computed Tomography Findings in Critically-ill Saudi Covid-19 Patients
Overview
Public Health
Authors
Affiliations
Background: Several, clinical and biochemical factors were suggested as risk factors for more severe forms of Covid-19. Macrophage inflammatory protein-1 alpha (MIP-1α, CCL3) is a chemokine mainly involved in cell adhesion and migration. Intracellular adhesion molecule 1 (ICAM-1) is an inducible cell adhesion molecule involved in multiple immune processes. The present study aimed to assess the relationship between baseline serum MIP-1α and ICAM-1 level in critically-ill Covid-19 patients and the severity of computed tomography (CT) findings.
Methods: The study included 100 consecutive critically-ill patients with Covid-19 infection. Diagnosis of infection was established on the basis of RT-PCR tests. Serum MIP-1α and ICAM-1 levels were assessed using commercially available ELISA kits. All patients were subjected to a high-resolution computed tomography assessment.
Results: According to the computed tomography severity score, patients were classified into those with moderate/severe (n=49) and mild (n = 51) pulmonary involvement. Severe involvement was associated with significantly higher MIP-1α and ICAM-1 level. Correlation analysis identified significant positive correlations between MIP-1α and age, D-dimer, IL6, in contrast, there was an inverse correlation with INF-alpha. Additionally, ICAM-1 showed significant positive correlations with age, D-Dimer,- TNF-α, IL6,while an inverse correlation with INF-alpha was observed.
Conclusions: MIP-1α and ICAM-1 level are related to CT radiological severity in Covid-19 patients. Moreover, these markers are well-correlated with other inflammatory markers suggesting that they can be used as reliable prognostic markers in Covid-19 patients.
Qi Y, Li C, Gao X, Zhang F J Int Med Res. 2025; 53(2):3000605251315923.
PMID: 39956620 PMC: 11831628. DOI: 10.1177/03000605251315923.
Utility of Protein Markers in COVID-19 Patients.
Alicia L, Maria Angeles O, Desiree M, Maximino R, Marilina G Int J Mol Sci. 2025; 26(2).
PMID: 39859366 PMC: 11766239. DOI: 10.3390/ijms26020653.
Condor Capcha J, Kamiar A, Robleto E, Saad A, Cui T, Wong A Proc Natl Acad Sci U S A. 2023; 120(48):e2308342120.
PMID: 37983492 PMC: 10691341. DOI: 10.1073/pnas.2308342120.